Formulation optimization and the absorption mechanisms of nanoemulsion in improving baicalin oral exposure

References

• Chen Y, Liu J, Angelov B, et al. Baicalin loaded in folate-PEG modified liposomes for enhanced stability and tumor targeting. Colloids Surf B Biointerfaces. 2016;140:74–82.
   PubMed Web of Science ®Google Scholar
• Kim SJ, Lee SM. Effect of baicalin on toll-like receptor 4-mediated ischemia/reperfusion inflammatory responses in alcoholic fatty liver condition. Toxicol Appl Pharmacol. 2012;258:43–50.
   PubMed Web of Science ®Google Scholar
• Li X, Liu Y, Wu T, et al. The antiviral effect of baicalin on enterovirus 71 in vitro. Viruses. 2015;7:4756–4771.
   PubMed Web of Science ®Google Scholar
• Waisundara VY, Siu SY, Hsu A, et al. Baicalin upregulates the genetic expression of antioxidant enzymes in Type-2 diabetic Goto-Kakizaki rats. Life Sci. 2011;88:1016–1025.
   PubMed Web of Science ®Google Scholar
• Baek JS, Hwang CJ, Jung HW, et al. Comparative pharmacokinetics of a marker compound, baicalin in KOB extract after oral administration to normal and allergic-induced rats. Drug Deliv. 2014;21:453–458.
   PubMed Web of Science ®Google Scholar
• Luan J, Zheng F, Yang X, et al. Nanostructured lipid carriers for oral delivery of baicalin: in vitro and in vivo evaluation. Colloids Surf A Physicochem Eng Aspects. 2015;466:154–159.
   Web of Science ®Google Scholar
• Lee D, Ko WK, Hwang DS, et al. Use of baicalin-conjugated gold nanoparticles for apoptotic induction of breast cancer cells. Nanoscale Res Lett. 2016;11:381.
   PubMed Web of Science ®Google Scholar
• Zhou X, Liu D, Zhao T, et al. Mechanical and baicalin delivery properties of adhesive matrices for iontophoretic flexible electrodes. J Biomater Sci Polym Ed. 2009;20:529–542.
   PubMed Web of Science ®Google Scholar
• Li N, Ye YJ, Yang M, et al. Pharmacokinetics of baicalin-phospholipid complex in rat plasma and brain tissues after intranasal and intravenous administration. Die Pharm Int J Pharm Sci. 2011;66:374–377.
   Google Scholar
• Xing J, Chen X, Zhong D. Absorption and enterohepatic circulation of baicalin in rats. Life Sci. 2005;78:140–146.
   PubMed Web of Science ®Google Scholar
• Wu H, Liu Z, Peng J, et al. Design and evaluation of baicalin-containing in situ pH-triggered gelling system for sustained ophthalmic drug delivery. Int J Pharm. 2011;410:31–40.
   PubMed Web of Science ®Google Scholar
• Hao J, Wang F, Wang X, et al. Development and optimization of baicalin-loaded solid lipid nanoparticles prepared by coacervation method using central composite design. Eur J Pharm Sci. 2012;47:497–505.
   PubMed Web of Science ®Google Scholar
• Zhang H, Zhao L, Chu L, et al. Preparation, optimization, characterization and cytotoxicity in vitro of Baicalin-loaded mixed micelles. J Colloid Interface Sci. 2014;434:40–47.
   PubMed Web of Science ®Google Scholar
• Li B, He M, Li W, et al. Dissolution and pharmacokinetics of baicalin–polyvinylpyrrolidone coprecipitate. J Pharm Pharmacol. 2013;65:1670–1678.
   PubMed Web of Science ®Google Scholar
• Yue PF, Li Y, Wan J, et al. Process optimization and evaluation of novel baicalin solid nanocrystals. Int J Nanomedicine. 2013;8:2961.
   PubMed Web of Science ®Google Scholar
• Wu H, Lu C, Zhou A, et al. Enhanced oral bioavailability of puerarin using microemulsion vehicle. Drug Dev Ind Pharm. 2009;35:138–144.
   PubMed Web of Science ®Google Scholar
• Tang TT, Hu XB, Liao DH, et al. Mechanisms of microemulsion enhancing the oral bioavailability of puerarin: comparison between oil-in-water and water-in-oil microemulsions using the single-pass intestinal perfusion method and a chylomicron flow blocking approach. Int J Nanomedicine. 2013;8:4415.
   PubMed Web of Science ®Google Scholar
• Parveen R, Baboota S, Ali J, et al. Oil based nanocarrier for improved oral delivery of silymarin: in vitro and in vivo studies. Int J Pharm. 2011;413:245–253.
   PubMed Web of Science ®Google Scholar
• Sun H, Liu K, Liu W, et al. Development and characterization of a novel nanoemulsion drug-delivery system for potential application in oral delivery of protein drugs. Int J Nanomedicine. 2012;7:5529.
   PubMed Web of Science ®Google Scholar
• Roohinejad S, Oey I, Wen J, et al. Formulation of oil-in-water β-carotene microemulsions: effect of oil type and fatty acid chain length. Food Chem. 2015;174:270–278.
   PubMed Web of Science ®Google Scholar
• Yuan Y, Li S, Mo F, et al. Investigation of microemulsion system for transdermal delivery of meloxicam. Int J Pharm. 2006;321:117–123.
   PubMed Web of Science ®Google Scholar
• Xiao Y, Chen X, Yang L, et al. Preparation and oral bioavailability study of curcuminoid-loaded microemulsion. J Agric Food Chem. 2013;61:3654–3660.
   PubMed Web of Science ®Google Scholar
• Ammar HO, Salama HA, Ghorab M, et al. Nanoemulsion as a potential ophthalmic delivery system for dorzolamide hydrochloride. AAPS PharmSciTech. 2009;10:808–819.
   PubMed Web of Science ®Google Scholar
• Gorain B, Choudhury H, Kundu A, et al. Nanoemulsion strategy for olmesartan medoxomil improves oral absorption and extended antihypertensive activity in hypertensive rats. Colloids Surf B Biointerfaces. 2014;115:286–294.
   PubMed Web of Science ®Google Scholar
• Gao F, Zhang Z, Bu H, et al. Nanoemulsion improves the oral absorption of candesartan cilexetil in rats: performance and mechanism. J Control Release. 2011;149:168–174.
   PubMed Web of Science ®Google Scholar
• Wang X, Jiang Y, Wang YW, et al. Enhancing anti-inflammation activity of curcumin through O/W nanoemulsions. Food Chem. 2008;108:419–424.
   PubMed Web of Science ®Google Scholar
• Wu H, Long X, Yuan F, et al. Combined use of phospholipid complexes and self-emulsifying microemulsions for improving the oral absorption of a BCS class IV compound, baicalin. Acta Pharm Sin B. 2014;4:217–226.
   PubMed Web of Science ®Google Scholar
• Akao T, Kawabata K, Yanagisawa E, et al. Balicalin, the predominant flavone glucuronide of scutellariae radix, is absorbed from the rat gastrointestinal tract as the aglycone and restored to its original form. J Pharm Pharmacol. 2000;52:1563–1568.
   PubMed Web of Science ®Google Scholar
• Bali V, Ali M, Ali J. Study of surfactant combinations and development of a novel nanoemulsion for minimising variations in bioavailability of ezetimibe. Colloids Surf B Biointerfaces. 2010;76:410–420.
   PubMed Web of Science ®Google Scholar
• Taiming L, Xuehua J. Investigation of the absorption mechanisms of baicalin and baicalein in rats. J Pharm Sci. 2006;95:1326–1333.
   PubMed Web of Science ®Google Scholar
• Dahan A, Hoffman A. Evaluation of a chylomicron flow blocking approach to investigate the intestinal lymphatic transport of lipophilic drugs. Eur J Pharm Biopharm. 2005;24:381–388.
   Google Scholar
• Lind ML, Jacobsen J, Holm R, et al. Intestinal lymphatic transport of halofantrine in rats assessed using a chylomicron flow blocking approach: the influence of polysorbate 60 and 80. Eur J Pharm Sci. 2008;35:211–218.
   PubMed Web of Science ®Google Scholar
• Yanez JA, Wang SW, Knemeyer IW, et al. Intestinal lymphatic transport for drug delivery. Adv Drug Deliv Rev. 2011;63:923–942.
   PubMed Web of Science ®Google Scholar
• Wu H, Zhou A, Lu C, et al. Examination of lymphatic transport of puerarin in unconscious lymph duct-cannulated rats after administration in microemulsion drug delivery systems. Eur J Pharm Sci. 2011;42:348–353.
   PubMed Web of Science ®Google Scholar
• Xing J, Chen X, Sun Y, et al. Interaction of baicalin and baicalein with antibiotics in the gastrointestinal tract. J Pharm Pharmacol. 2005;57:743–750.
   PubMed Web of Science ®Google Scholar
• Zhao L, Wei Y, Huang Y, et al. Nanoemulsion improves the oral bioavailability of baicalin in rats: in vitro and in vivo evaluation. Int J Nanomedicine. 2013;8:3769.
   PubMed Web of Science ®Google Scholar